Investing.com - Ideaya Biosciences Inc (NASDAQ: IDYA) reported third quarter EPS of $-0.46, $0.03 better than the analyst estimate of $-0.49. Revenue for the quarter came in at $8.04M versus the consensus estimate of $8.14M.
Ideaya Biosciences Inc's stock price closed at $28.93. It is up 13.45% in the last 3 months and up 60.45% in the last 12 months.
Ideaya Biosciences Inc saw 6 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Ideaya Biosciences Inc's stock price’s past reactions to earnings here.
According to InvestingPro, Ideaya Biosciences Inc's Financial Health score is "good performance".
Check out Ideaya Biosciences Inc's recent earnings performance, and Ideaya Biosciences Inc's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar